As nearly seven million patients remain on National Health Service waiting lists, the British healthcare system continues to search for new ways to improve efficiency. Frontier Health, a young technology company, has announced a $16 million funding round led by Atomico to accelerate the deployment of its artificial intelligence platform, JUNO.
Unlike many of the AI tools developed in recent years to assist doctors with clinical documentation and medical record-keeping, JUNO is aimed at a group that has received far less attention: the administrative teams responsible for coordinating patient care, tracking test results, and managing treatment pathways within hospitals.
According to data provided by the company, an initial deployment at East Sussex Healthcare NHS Trust delivered significant operational improvements. Over an eight-week period, the system reportedly saved the equivalent of 221 staff days and reduced median patient pathway times by 22%.
For Atomico, one of Europe’s best-known technology investors, these results offered unusually strong evidence of effectiveness for a company at such an early stage. “Most enterprise AI companies are still seeking proof that their technology works in real-world environments,” said Andreas Helbig, a partner at the firm. “Frontier Health already has that proof inside one of the world’s most demanding healthcare systems.”
Founded in 2024 by Rachel Finegold, Frontier Health benefits from extensive experience within the NHS. Before launching the company, Finegold spent six years leading healthcare initiatives at Palantir Technologies, working with more than forty NHS hospitals and gaining first-hand insight into the operational challenges facing the system.
The investment also reflects a broader shift in thinking about healthcare AI. To date, much of the sector’s funding has flowed toward tools designed for clinicians. Administrative functions, despite playing a critical role in patient flow and service delivery, have attracted relatively little attention from investors.
Yet many healthcare leaders now argue that long waiting lists are driven not only by shortages of clinical capacity but also by operational failures, including missed follow-ups, delayed responses to test results, and bottlenecks in patient coordination.
With the new funding, Frontier Health plans to expand JUNO across additional NHS Trusts, enhance its technology, and grow its workforce.
